GoodRx Holdings (GDRX) | Stock Overview & Key Data
GoodRx Holdings Performance Comparison
Stock Range
Today's Range
Low: $4.68
High: $4.84
on July 18, 2025
52 Week Range
Low: $3.67
High: $9.26
on May 7, 2025
on July 25, 2024
All-Time High: $64.22 on September 28, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.7B
EPS
0.07
P/E Ratio (TTM)
67.57
Forward P/E
11.54
P/B Ratio
2.61
PEG Ratio
11.54
Div. Yield
N/A
ROE
4.43%
Beta
1.166
Debt to Equity
82.71
Financial Highlights
Profitability
Gross Margin
93.42%
Operating Margin
13.69%
Profit Margin
3.57%
Returns and Earnings
Return on Assets (TTM)
4.26%
Return on Equity (TTM)
4.43%
EBITDA
$173.3M
Net Income (TTM)
$28.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$2.08
Quarterly Revenue Growth (YoY)
2.60%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| GoodRx Holdings GDRX | 1.69B Small-cap | -1.27% | 4.46% | 7.09% | -0.64% | 2.63% | -44.35% | -28.55% | -90.91% |
| Veeva Systems VEEV | 45.73B Large-cap | 2.32% | 0.31% | 34.37% | 26.56% | 34.05% | 50.86% | 29.33% | 9.73% |
| Ge Healthcare GEHC | 34.91B Large-cap | 1.10% | 5.66% | 25.60% | -13.03% | -3.09% | -5.22% | 34.37% | 34.37% |
| Premier PINC | 1.94B Small-cap | -0.62% | -5.93% | 8.44% | -5.16% | -1.97% | 7.66% | -43.77% | -39.30% |
| Certara CERT | 1.69B Small-cap | -8.93% | -4.45% | -30.20% | -19.90% | -5.25% | -34.45% | -51.58% | -72.32% |
| Schrodinger SDGR | 1.56B Small-cap | 2.09% | 1.90% | -18.10% | 0.56% | 5.15% | 1.31% | -31.25% | -71.61% |
Ownership & Short Interest
Insider Ownership
12.49%
Institutional Ownership
62.84%
Shares Short
5M
Short Ratio
3.72
Short % of Shares Outstanding
5.12%
Average 10-Day Volume
1M
Average 90-Day Volume
2M
GoodRx Holdings Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in GoodRx Holdings would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GDRX's 52-week high and low?
- In the last 52 weeks, GoodRx Holdings reached a high of $9.26 (on July 25, 2024) and a low of $3.67 (on May 7, 2025).
- What is the market cap and P/E ratio for GDRX?
- Curious about GoodRx Holdings's size and valuation? Its market capitalization stands at 1.69B. When it comes to valuation, the P/E ratio (trailing twelve months) is 67.57, and the forward P/E (looking ahead) is 11.54.
- Does GDRX pay dividends? If so, what's the yield?
- As for dividends, GoodRx Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are GoodRx Holdings's main competitors or similar companies to consider before investing?
When looking at GoodRx Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV45.73B Healthcare Health Information Services 50.86% 29.33% Ge Healthcare
GEHC34.91B Healthcare Health Information Services -5.22% 34.37% Premier
PINC1.94B Healthcare Health Information Services 7.66% -43.77% Certara
CERT1.69B Healthcare Health Information Services -34.45% -51.58% Schrodinger
SDGR1.56B Healthcare Health Information Services 1.31% -31.25% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for GoodRx Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of GoodRx Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.43%, the Debt to Equity ratio from the most recent quarter is 82.71, and its Gross Profit Margin stands at 93.42%.
- What is the recent revenue and earnings growth for GDRX?
- Looking at GoodRx Holdings's growth, its revenue over the trailing twelve months (TTM) was $797M. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.60%, and quarterly earnings saw a YoY growth of N/A.
- How much of GDRX stock is held by insiders and institutions?
- Wondering who owns GoodRx Holdings stock? Company insiders (like executives and directors) hold about 12.49% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 62.84%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.